SDGR Schrodinger Inc
Company Analysis
Latest News
Schrödinger Swings to Profit and Lands a Big Pharma AI Deal — But Can a Milestone-Driven Quarter Sustain the Rally?
Shares of Schrödinger surged as much as 10.2% to $18.07 after the computational drug-discovery company posted second-quarter results that flipped a year-ago...
🟢 Schrodinger is trading 10% up today after Q2 revenue beat and positive net income
Schrodinger is trading at $18.05, up +10.06% now, after August 5 earnings showed a substantial revenue and profitability improvement. • Q2 revenue reached...
🟢 Schrodinger is trading 9% up today after second-quarter results beat expectations
Schrodinger is trading 9% up at $18.07 after its August 5, 2026, second-quarter results exceeded expectations. - Revenue reached $58.9 million, net income...
Schrödinger's second quarter revenue of $58.9M beats estimates, swings to profit on collaboration milestone and investment gain
Schrödinger reported second quarter 2026 total revenue of $58.9 million, an 8% increase year-over-year, beating analyst expectations. The company reported a...
Schrödinger Inc Q2 2026 Earnings Preview: What Analysts Expect on August 05, 2026
Schrödinger is expected to report Q2 2026 revenue of $47.2 million and a consensus EPS loss of $0.60, with the stock currently trading at $15.14 against an...
Schrödinger launches Bunsen AI co-scientist, partnering with NVIDIA and Google
Schrödinger has released an early access version of Bunsen, an AI-powered platform for molecular discovery. The system acts as a co-scientist by combining...
🔴 Schrodinger is trading 5.4% down today amid broader risk-off pressure in tech and growth stocks
Schrodinger is trading at $15.38 (-5.44%) as the stock faces pressure amid a broader risk-off environment for technology and growth-oriented companies. • No...